Abstract

Huntington disease is associated with elongation of a CAG repeat in the HTT gene that results in a mutant huntingtin protein. Several studies have implicated N-terminal huntingtin protein fragments in Huntington disease pathogenesis. Ideally, these fragments are studied in human brain tissue. However, the use of human brain tissue comes with certain unavoidable variables such as post mortem delay, artefacts from freeze-thaw cycles and subject-to-subject variation. Knowledge on how these variables might affect N-terminal huntingtin protein fragments in post mortem human brain is important for a proper interpretation of study results. The effect of post mortem delay on protein in human brain is known to vary depending on the protein of interest. In the present study, we have assessed the effect of post mortem delay on N-terminal huntingtin protein fragments using western blot. We mimicked post mortem delay in one individual control case and one individual Huntington disease case with low initial post mortem delay. The influence of subject-to-subject variation on N-terminal huntingtin fragments was assessed in human cortex and human striatum using two cohorts of control and Huntington disease subjects. Our results show that effects of post mortem delay on N-terminal huntingtin protein fragments are minor in our individual subjects. Additionally, one freeze-thaw cycle decreases the huntingtin western blot signal intensity in the cortex control subject, but does not introduce additional N-terminal huntingtin fragments. Our results suggest that subject-to-subject variation contributes more to variability in N-terminal huntingtin fragments than post mortem delay.

Highlights

  • Our study shows a small effect of artificially induced post mortem delay (PMD) on N-terminal htt fragments in cortex tissue from one control subject, and in striatal tissue from one Huntington disease (HD) subject

  • We detected N-terminal fragments of the same molecular weight compared with the non-frozen tissue, but western blot bands corresponding to full-length and N-terminal htt fragments of more than 100 kDa became weaker with increasing artificial PMD (Fig 1B)

  • By mimicking PMD and a freeze-thaw cycle separately, we were able to provide a preliminary overview of expected effects on N-terminal htt fragments in post mortem human brain tissue

Read more

Summary

Methods

Post mortem human cortex and striatal brain tissue from control and HD subjects was obtained from the Neurological Foundation of New Zealand Human Brain Bank, Centre for Brain Research, University of Auckland. The temporal cortex tissue was obtained 1 hour after surgery on a patient suffering from severe epilepsy. Tissue was obtained with the approval by the University of Auckland Human Participants Ethics Committee. Informed written consent was obtained in all cases. None of the donors were from a vulnerable population and all donors or of kin provided written informed consent that was freely given. See the website of the Neurological Foundation of New Zealand Human Brain Bank for more information: http://neurological.org.nz/what-we-do/human-brain-bank.

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call